Loading stock data…
Medtronic plc. (MDT)
$80.93-0.05 (-0.06%)
After Hours$81.43+0.50 (+0.61%)· Last close Jun 29
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Medtronic plc in the Healthcare sector is trading at $80.93 with a market capitalization of $100.1B. Wall Street consensus targets $97.77 (26 analysts), implying a +20.8% move over the next 12 months. The stock is currently 24% below its 52-week high of $106.33, remaining 10.0% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +20.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.02B↑ | $8.96B↑ | $8.58B↓ | $8.93B↑ | $8.29B |
| Gross Profit | $5.76B↓ | $5.90B↑ | $5.58B↓ | $5.78B↑ | $5.51B |
| Operating Income | $1.60B↓ | $1.70B↑ | $1.52B↓ | $1.80B↑ | $1.71B |
| Net Income | $1.14B↓ | $1.37B↑ | $1.04B↓ | $1.06B↓ | $1.29B |
Peer Comparison
JNJUNHPFE
Fundamentals
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable car...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$100.08B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.77
Beta
Defensive asset. Lower volatility than the S&P 500.
0.63
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.88%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.42%
Volume
Today's trading volume
6.50M
Recent News
GMED vs. MDT: Which Medical Stock Has More Upside Potential?
Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside may give it the edge despite a richer valuation.
How Abbott's Largest Segment Is Preparing for the Next Growth Phase
ABT's Medical Devices unit builds on strong growth with new diabetes, heart rhythm and electrophysiology advances ahead of Q2 2026.
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic
Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.
Here is Why Medtronic (MDT) is One of the Best Long Term Stocks to Buy According to Hedge Funds
Medtronic (NYSE:MDT) is one of the best long term stocks to buy according to hedge funds. On June 8, Medtronic received FDA 510(k) clearance for its Nellcor pulse oximetry system featuring the new Nell-EQ intelligent processor. This technology is engineered to provide more consistent and reliable pulse rate and oxygen saturation monitoring across various patient […]
3 Stocks I'm Not Selling No Matter What the Market Does
I focus on well-run companies that pay reliable dividends; a bull or bear market doesn't change how well a company is run.